| Name | Letaplimab |
|---|
| Description | Letaplimab (IBI-188) is a humanized IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPα. Letaplimab enhances tumor cell phagocytosis[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |